Although licensed for Type 2 Diabetes, Rybelsus has become popular and acknowledged for it's aid in helping people lose weight, much the same way Liraglutide (Victoza/Saxenda) and Semaglutide (Ozempic/Wegovy) started their lives - for Type 2 diabetes, with promising results for weight loss, to being re-branded and re-licensed for weight loss
Hashimoto's and GLP-1 Microdosing Hashimoto's and GLP-1 Microdosing GLP-1 microdosing for Hashimoto's is a "low and slow" protocol that uses fractional doses of GLP-1 receptor agonists to reduce metabolic inflammation without triggering acute immune responses
I think the second thing is going to be bigger than the first so maybe the first $10 million should come from me
The May 2026 Regulatory Environment: What Changed and What It Means for Eden Patients Anyone evaluating a compounded GLP-1 program in May 2026 is making that decision against a regulatory backdrop that has shifted dramatically from 2022, when compounded semaglutide and tirzepatide first became widely available through telehealth platforms
Antioxidant activity of hydrogen water mask pack composed of Gel-Type emulsion and hydrogen generation powder
This creates an odd incentive structure